Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 4.07 USD 1.24% Market Closed
Market Cap: 539.6m USD
Have any thoughts about
Organogenesis Holdings Inc?
Write Note

Relative Value

The Relative Value of one ORGO stock under the Base Case scenario is 5.93 USD. Compared to the current market price of 4.07 USD, Organogenesis Holdings Inc is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORGO Relative Value
Base Case
5.93 USD
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
88
Median 3Y
0.9
Median 5Y
1.3
Industry
7.7
Forward
1.2
vs History
vs Industry
3
Median 3Y
19.7
Median 5Y
12.1
Industry
22.7
Forward
-23.5
vs History
14
vs Industry
10
Median 3Y
14.9
Median 5Y
14.3
Industry
21.6
vs History
vs Industry
2
Median 3Y
-24.5
Median 5Y
-24.5
Industry
25.2
vs History
60
vs Industry
54
Median 3Y
1.6
Median 5Y
3.4
Industry
2.5
vs History
58
vs Industry
79
Median 3Y
0.9
Median 5Y
1.5
Industry
7.7
Forward
1.1
vs History
58
vs Industry
75
Median 3Y
1.1
Median 5Y
2
Industry
9
vs History
23
vs Industry
9
Median 3Y
11.9
Median 5Y
11.9
Industry
4.2
Forward
29.4
vs History
9
vs Industry
4
Median 3Y
16.8
Median 5Y
16.8
Industry
4.1
Forward
-23.6
vs History
14
vs Industry
10
Median 3Y
13.7
Median 5Y
13.1
Industry
5.7
vs History
4
vs Industry
3
Median 3Y
31
Median 5Y
21.1
Industry
3.6
vs History
58
vs Industry
58
Median 3Y
1.2
Median 5Y
2.5
Industry
4.6

Multiples Across Competitors

ORGO Competitors Multiples
Organogenesis Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organogenesis Holdings Inc
NASDAQ:ORGO
539.6m USD 1.2 -73.1 18.7 50.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average P/E: 208
Negative Multiple: -73.1
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average EV/EBITDA: 17.4
18.7
64%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average EV/EBIT: 26.4
50.1
14%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top